Zynex Inc (ZYXI) 0.1700 $ZYXI Zynex files 510(k)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Zynex Inc (ZYXI) 0.1700 $ZYXI

Zynex files 510(k) application with US FDA for CM1500 for monitoring blood volume
M2 - Thu Sep 24, 5:50AM CDT
Medical technology company Zynex (Other OTC:ZYXI) said on Wednesday that it has filed an 510(k) application with the Food and Drug Administration pursuant to Section 510(k) of the Food, Drug and Cosmetic Act for clearance of its new CM1500 monitoring device.

Zynex, Inc. Announces FDA Filing for Blood Volume Monitor
ACCESSWIRE - Wed Sep 23, 1:56PM CDT
510(K) Application Filed For CM1500 with the Food and Drug Administration

Zynex Announces Second Quarter 2015 Results
Marketwired - Thu Aug 13, 7:00AM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neuro diagnostics, cardiac monitoring and compound pharmacy, announced today its second quarter 2015 financial results.

Zynex Schedules Second Quarter 2015 Earnings Release and Webcast
ACCESSWIRE - Thu Aug 06, 7:01AM CDT
LONE TREE, CO / ACCESSWIRE / August 6, 2015 / Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today that it will host the Company's second quarter investor webcast on Thursday, August 13, 2015 at 9:00 a.m. Mountain Time (11:00 a.m. Eastern Time.)

Zynex passes DMEPROS programme accreditation upon meeting strict quality, integrity and effectiveness standards
M2 - Thu Jul 02, 8:19AM CDT
Zynex (OtherOTC:ZYXI) revealed on Wednesday that it has received accreditation for its Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) programme from the Accreditation Commission for Health Care.

Zynex Receives DMEPROS Program Accreditation
PRWeb - Wed Jul 01, 8:05AM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today it has been awarded accreditation for its Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) program from the Accreditation Commission for Health Care.

Zynex updates Q2 2015 revenue in USD3.2m to USD3.5m range
M2 - Mon Jun 15, 4:43AM CDT
Medical technology company Zynex (OtherOTC:ZYXI) said on Friday that it expects its revenue to be in the range of USD3.2m to USD3.5m for the second quarter ending 30 June 2015.

Zynex Receives Response from FDA on Blood Volume Monitor
GlobeNewswire - Fri Jun 12, 11:22AM CDT
via PRWEB - Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today it has received a response from the FDA concerning the basis for filing its application for approval of its new Blood Volume Monitor. As such, the Company has begun to prepare its request for approval pursuant to Section 510(k) of the Food, Drug and Cosmetic Act.

Zynex Provides Updated Guidance for the Second Quarter 2015
GlobeNewswire - Fri Jun 12, 8:07AM CDT
via PRWEB - Zynex, Inc. (OTCQB:ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today it currently expects revenue for the quarter ending June 30, 2015 to be higher than revenue reported in the first quarter of 2015 and be in the range of $3.2 million to $3.5 million. The lower estimate is primarily the result of notification from TRICARE, the health care program for uniformed service members, that it would no longer accept claims related to compound transdermal pain creams.

WEALTHMAKERS.COM: Zynex, Inc. (ZYXI) is Undervalued With Short Term Bullish Patterns and Pending Short Squeeze
M2 - Thu May 21, 10:18AM CDT
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has initiated coverage today on Zynex Inc. (OTC: ZYXI). The report highlights the short term bullish pattern that has emerged, the SqueezeTrigger Price of $0.659 and the projected short squeeze valuation of $0.86 per share.

Zynex Receives 44th Pharmacy License Approval
GlobeNewswire - Thu May 21, 7:33AM CDT
via PRWEB - Zynex, Inc. (OTCQB:ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today that it has received license approval from the State of Arkansas for its compound pharmacy business Pharmazy. This brings to 44 the total states, including the District of Columbia, in which the Company is licensed to provide compound pharmacy services.

Zynex Retains BUYINS.NET to Surveil Market Maker and Short Sellers
PRWeb - Tue May 19, 8:10AM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics and compound pharmacy, announced today it has retained Buyins.net to initiate coverage and compliance monitoring, short sale trading statistics and market integrity surveillance on its stock. Buyins.net monitors ZYXI market-makers daily for compliance with Fair Market-Making Requirements, and released its first short sale data report on ZYXI on May 14, 2015. The report indicates a SqueezeTrigger price for all ZYXI shares shorted to be $0.66 per share. To view the report or get a more detailed description of the SqueezeTrigger and other indicators, go to http://www.buyins.net and enter "ZYXI" in the search box.

BUYINS.NET Issues Zynex (ZYXI) SqueezeTrigger Report
M2 - Fri May 15, 7:12AM CDT
BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on Zynex, Inc. (OTC: ZYXI) after releasing the latest short sale data through May 14, 2015. The total aggregate number of shares shorted since August 2009 is approximately 7.26 million shares. Approximately 36.52% of daily trading volume is short selling. The SqueezeTrigger price for all ZYXI shares shorted is $0.66. A short squeeze is expected to begin when shares of ZYXI close above the $0.66 SqueezeTrigger price.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lecanemab Shines in 5-Year Alzheimer's Study at CTAD

Updated Category News Views 19

Latest Lecanemab Results Turn Heads at CTAD 2026 The whispers buzzing out of the CTAD 2026 conference are about something promising for those in the trenches of Alzheimer's research: lecanemab. Yep, it's a name that's been bandied about before, and this time it's the long-term data doing the talking. The five-year results from Eisai and Biogen's lecanemab study are...

Continue Reading
MISUMI Americas Expands, Ventures into New Horizons

Updated Category News Views 84

Marking New Territory in Monterrey MISUMI Americas is planting a new flag down in Monterrey, Mexico, with a sprawling 45,000-square-foot facility. This isn't just another expansion; it's a strategic move that's bound to shake things up in the manufacturing sector south of the border. When you've got a player like MISUMI widening their footprint, it catches the eye. Why?...

Continue Reading
Cheyenne Real Estate: Neighborhood Nuances and Choices

Updated Category News Views 25

Unearthing the Hidden Dynamics of Cheyenne's Real Estate You've got this picturesque vision in your head of Cheyenne, Wyoming—a sprawling cowboy town with its wild winds and wide-open spaces. But if you think all those neighborhoods are cut from the same cloth, you've got another thing coming. The real estate scene here is just as varied as the prairies stretching out...

Continue Reading
Tigo Energy Faces Lawsuit: Key Details for Investors

Updated Category News Views 74

Tigo Energy Inc.'s Troubles: A Stock Drop and Legal Woes You see, not every day do you wake up to find your investment taking a nose dive by 36.76%. But that’s exactly what happened to Tigo Energy, Inc. (NASDAQ: TYGO) after some shaky announcements. A Rollercoaster for Investors On August 4, 2026, Tigo hit investors with a one-two punch: revised financial outlook and...

Continue Reading
Sue Egstrand to Lead Karo's Next Growth Phase

Updated Category News Views 152

A New Captain at Karo’s Helm Karo Healthcare is bracing for an exciting ride. Sue Egstrand’s appointment as the new CEO pulls the curtain on what might just be a game-changing era for the company. Set to take the wheel on January 1, 2027, Egstrand brings a heavy-hitting resume—a mash-up of pharmaceutical prowess and a deep-dive into consumer healthcare. Sue’s...

Continue Reading
CICYBELL's Black Friday Is a Fashionist's Dream

Updated Category News Views 130

Stepping Into the Fashion Frenzy It’s that time of year again, where shoppers are girding up for Black Friday. And here comes CICYBELL, ready to dish up some meaty discounts that would turn even the most hardened cynic into a frenzied shopper. Alright, maybe that’s a touch dramatic, but let’s break down what this fashion brand is cooking up in their latest sale....

Continue Reading
Carolina Pines Tackles Rural Healthcare Myths on TV

Updated Category News Views 133

Rural Healthcare Battles the Big City Myth Picture this: you're in a tiny town where everyone knows your dog's name, but some think you've got to head to the city for top-notch medical care. That's where Carolina Pines Regional Medical Center steps in. They’ve snagged a spot on 'All Access with Andy Garcia', shining a light on how investments in tech and talent keep...

Continue Reading
Choate's Expands to New Mid-South Markets

Updated Category News Views 21

Family Traditions Drive Choate's Growth Back in the day, you might've thought the family-run businesses were a dying breed, right? Not in the case of Choate's Air Conditioning, Heating, Plumbing & Electrical. These folks aren't just holding the fort; they're storming new territories across the Mid-South like they've got something to prove—or maybe just something to...

Continue Reading
Qfin Holdings Faces Securities Fraud Lawsuit Scrutiny

Updated Category News Views 23

Qfin Holdings Stumbles Under Legal Microscope Picture this—you're riding the stock market wave and then, out of nowhere, your investment gets hit by a sudden drop, leaving you scrambling for answers. That's the scenario investors in Qfin Holdings, Inc. (NASDAQ: QFIN) find themselves in after the company’s stock plunged by nearly 19%. Now, they're not just left...

Continue Reading
AI Alliance Rethinks Health Plan Engagement

Updated Category News Views 44

Building Bridges in Healthcare Ever seen healthcare stuck in its own muck with disconnected gears attempting to move the same machine? Well, that's precisely the mountain healthplans.ai and URAWARRIOR aim to climb down from. Founders Rachel Spilo and Dr. Bershan Shaw are gearing up to shake hands in their no-nonsense, real-world vow to sync member engagement with the...

Continue Reading

Top 5 Most Recently Viewed Articles

Key Insights into Rathbones Group Plc's Position Disclosure

Updated Category News Views 171

Understanding Disclosure Requirements in Financial Markets In the world of finance and investments, transparency is paramount. Investors and market participants must be aware of regulations surrounding disclosure, especially when significant interest in relevant securities occurs. Here, we delve into key details surrounding a recent public disclosure by Rathbones Group...

Continue Reading
Atkore Inc. Announces Quarterly Cash Dividend for Shareholders

Updated Category News Views 139

Atkore Inc. Announces Cash Dividend for Shareholders Atkore Inc. (NYSE: ATKR), a prominent manufacturer known for its extensive electrical products, has informed its investors about the declaration of a quarterly cash dividend. This announcement signifies the company's ongoing commitment to providing value to its shareholders. The dividend is set at $0.32 per share of...

Continue Reading
Innovating Home Textiles: How CiCLO® is Changing Luxury Fabrics

Updated Category News Views 248

Innovative Technologies in Home Textiles An innovative fiber design blending renewable and biodegradable materials is advancing comfort, longevity, and responsible performance in premium home and hospitality textiles. At Heimtextil 2026, Intrinsic Advanced Materials will showcase a new generation of luxury textiles that embody sustainable practices, collaborating with...

Continue Reading
Vegan Food Industry Set for Huge Growth: USD 55.88 Billion by 2034

Updated Category News Views 271

Overview of the Vegan Food Market Growth The global vegan food market is anticipated to witness significant growth, increasing from USD 20.22 billion to an impressive USD 55.88 billion by 2034. This remarkable shift, with a compound annual growth rate (CAGR) of 10.7% from 2025 to 2034, reflects the rising consumer demand for plant-based options. Consumer Trends Driving...

Continue Reading
BAOS Stock Hits New Heights with Investor Enthusiasm

Updated Category News Views 190

BAOS Stock Surges to 52-Week High In a remarkable display of market confidence, Baosheng Media Group Holdings Limited (BAOS) has achieved a significant milestone by reaching a 52-week high of $7.33 per share. This surge demonstrates the strong backing from investors and the company's solid financial standing. Company Valuation and Financial Health The micro-cap company,...

Continue Reading